A non-viral system for getting gene therapy into cells by Arlene Weintraub Friday, December 6, 2019 Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.
How new gene discoveries could guide precision medicine in MS by Arlene Weintraub Thursday, October 31, 2019 Newly identified gene variants that play a role in MS-related vision loss could help guide precision medicine and drug development, researchers say.
Johns Hopkins unveils $17M center for psychedelics research by Amirah Al Idrus Friday, September 6, 2019 With a new, privately funded research center, Johns Hopkins is trying to jump-start psychedelic research that has been stymied since the 1970s.
New evidence shows a link between Parkinson’s and the gut by Angus Liu Wednesday, June 26, 2019 Johns Hopkins scientists found that misfolded alpha-synuclein protein can travel from the gut and drive Parkinson's disease.
Viracta's combo garners high response in EBV-linked lymphoma by Arlene Weintraub Monday, June 3, 2019 A combination of Viracta Therapeutics' nanatinostat and an antiviral drug produced a 58% response rate in an early trial.
Thrive launches with $110M, Johns Hopkins liquid biopsy tech by Amirah Al Idrus Thursday, May 30, 2019 Thrive debuted with $110 million, liquid biopsy technology from Johns Hopkins and Third Rock's Steve Kafka at the helm to catch cancer earlier.
WindMIL Therapeutics' interim CEO steps up to the plate by Amirah Al Idrus Thursday, April 25, 2019 Donald Hayden, who joined WindMIL Therapeutics as executive chairman and then interim CEO, will become the company's permanent CEO.
FDA clears Sonavex’s ultrasound blood flow monitor by Amirah Al Idrus Tuesday, March 12, 2019 Sonavex scored FDA clearance for its technology that uses ultrasound imaging and deep learning to deliver blood flow data on demand.
Substance abuse and more identified as drivers of brain aging by Angus Liu Monday, August 27, 2018 Brain scans of more than 30,000 individuals showed cerebral blood flow fluctuation related to age.
Boosting cancer immunotherapy by switching off a protein by Angus Liu Friday, August 3, 2018 Suppressing the YAP protein, known for its role in modulating cell death, may help free up the immune system to fight cancer.